Avra Medicines, Inc. — Form D

Avra Medicines, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-03-26. The offering totals $750, of which $750 was reported sold. Industry: Biotechnology.

Offering

• Filed: 2014-03-26
• Form: D
• Accession: 0001600380-14-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $750
• Amount sold: $750
• Investors: 4
• Date of first sale: 2014-03-25
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-214274

Issuer

• Name: Avra Medicines, Inc.
• CIK: 0001600380
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 405 WALTHAM STREET, LEXINGTON, MA, 02421
• Phone: 6175007848

Officers, directors & promoters (2)

More

• CIK 1600380 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search